Federal officials counter that the reward to the taxpayer is not money but the drug itself. " This is exactly the way things should work," said Dr. Steven Rosenberg, who has led the surgery branch at the National Cancer Institute for 42 years and led development of Kiteâ€™s drug. Such partnerships, he said, are "absolutely essential or many discoveries will not see the light of day. 